Expanded Access to VAL-083
NCT03138629
·
clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Cancer
Interventions
DRUG:
VAL-083
Sponsor
Kintara Therapeutics, Inc.